About NeuroNexus
NeuroNexus is a full-stack electrophysiology company: neural probes, instruments and software, engineered together for neural recording and stimulation. The company was spun out of the University of Michigan in 2004 to make the Michigan silicon probe a product. It is run by its founders, has been independently owned since 2019, and is based in Ann Arbor, Michigan.
What we make
Since 2004 NeuroNexus has supplied neural probes, electrode arrays, instruments and software to electrophysiology laboratories worldwide. 5,000+ peer-reviewed publications cite the technology, from 1,000+ labs on six continents.
Neural probes and electrode arrays
Silicon probes, surface grids, cuff electrodes and 3D arrays for CNS, PNS, cardiac and organoid work: 210+ silicon-probe designs and 50+ polymer grid designs.
ElectrodesData acquisition and instruments
XDAQ recording and stimulation systems, Smartbox for SiNAPS probes, headstages, microdrives and optogenetics equipment.
SystemsRadiens software
A local-first platform: Allego for acquisition, Videre for analysis and curation, and Radiens Compute with the free RadiensPy client.
RadiensCore values
The company's stated purpose is empowering discovery in the life sciences. Six values describe how the team works.
Innovation
We are scientists, and we keep looking for faster and simpler ways to do the research.
Drive
The right solution is not always obvious. We keep working until we find it.
Resilience
When something fails, we work the problem until it is solved.
Collaboration
Discovery is collaborative. We work with researchers to build tools fitted to their experiments.
Integrity
Nothing we do comes at the cost of a customer's trust.
Excellence
Each of us answers for the quality of our own work.
History
Twenty-two years of making neural probes, under independent ownership for all but seven of them.
01.
2004 — Founded
Spun out of the University of Michigan by Daryl Kipke, Rio Vetter and Jamille Hetke to make the Michigan silicon probe a product.
02.
2012 — Acquired by Greatbatch (now Integer)
Became part of a public medical-technology company.
03.
2019 — Independent again
The founders, with Tom Hook, formed the NEL Group and bought NeuroNexus back, ending seven years of corporate ownership.
04.
Today — Founder-led
Privately held and run by its founders.
Leadership
Daryl R. Kipke
CEO of NeuroNexus and NEL Group, Inc., Founder, and Director of NeuroNexus and NEL Group, Inc.
Ph.D., University of Michigan
Dr. Daryl R. Kipke co-founded NeuroNexus in 2004 to commercialize the silicon neural probe developed at the University of Michigan, where he was Professor of Biomedical Engineering and Director of the Center for Neural Communication Technology. A serial neurotechnology entrepreneur, he has founded three companies and taken two to acquisition: Neural Intervention Technologies (W.L. Gore) and NeuroNexus (Greatbatch, now Integer, 2012). In 2019 he formed the NEL Group to buy NeuroNexus back, returning it to the independent, founder-led company he leads today, and brought on veteran medtech CEO Tom Hook as partner and fellow director. His research on neural interfaces that communicate with circuits in the brain, spinal cord and autonomic nervous system has produced more than 200 scientific publications and numerous patents. He is a Fellow of the AIMBE.
Rio Vetter
Co-Founder; Chief Operating Officer and Chief Technology Officer
Ph.D., University of Michigan
Since co-founding NeuroNexus in 2004, Dr. Rio Vetter has established himself as an accomplished executive and inspiring leader. Responsible for planning and directing all aspects of NeuroNexus' technical infrastructure, Dr. Vetter's strategic vision blends science, technology, and innovation with the commercial interests of the company. With technical experience in biomedical engineering, neuroscience, electronic systems, and software signal processing algorithms that interface with the nervous/cardiac systems, Dr. Vetter understands the demands of the industry. He orchestrates the objectives of different groups to create a cohesive technology pipeline that starts with research and ends with the manufacturing of innovative, sellable products. Dr. Vetter has a BSE and MSE in Biomedical Engineering from Arizona State University and a Ph.D. in Biomedical Engineering from the University of Michigan. His research has led to the creation of 30+ patents and numerous scientific publications.
Jamille Hetke
Co-Founder; VP for Engineering
M.S., University of Michigan; AIMBE Fellow
One of NeuroNexus's co-founders, Jamille Hetke brings extensive experience in neural probe design, MEMS processing, and advanced packaging to her current role as VP for Engineering. The lead engineer of neural interface projects and chief designer of neural probes, she is actively involved with product development, executive management, and the exploration of new business opportunities. Ms. Hetke's neural probe journey began at the University of Michigan, where she served on the Michigan Probe development team for over two decades. She received a B.S. in Electrical Engineering from Michigan State University and an M.S. in Biomedical Engineering from the University of Michigan. A fellow in the American Institute of Medical and Biological Engineering, Ms. Hetke is recognized as a leader in her field — her work has resulted in over 25 patents and numerous scientific publications.
Priyanka Sehgal
Senior Director of Operations
M.S., Wayne State University
As the Director of Operations at NeuroNexus, Priyanka Sehgal oversees the day-to-day operations of the company, ensuring that everything runs efficiently. Through this role, Ms. Sehgal was responsible for standardizing production and test processes – this has been instrumental in minimizing manufacturing variability. She is actively involved in the development and integration of new technologies. Before her promotion to Director, Ms. Sehgal headed the quality and manufacturing department. Working in this capacity, she designed and implemented the company's quality management system. Ms. Sehgal has a BS in Biomedical Engineering from Maharshi Dayanand University in India and an MS in Biomedical Engineering from Wayne State University, Michigan.
Sales and applications
Jeffrey Adams
Product Engineer
B.S., Michigan State University
While working as part of the sales team, Jeffrey Adams developed a wealth of knowledge about the NeuroNexus product line. Today, he uses these insights in his capacity as a Product Engineer. In addition to supporting sales and marketing initiatives, he heads the Quality Assurance team. Jeffrey received a BS in Engineering from Michigan State University.
Nicolas Alba
Senior Account Executive and Application Scientist
Rosie Rae
Application Scientist and Head of Marketing
Ph.D., Medical University of South Carolina
Dr. Rosie Rae is a tenacious, positive, and driven scientist with expertise in neurophysiology and data analysis. She is passionate about rigorous, ethical science and committed to making complex research accessible and understandable for all audiences. As an Application Scientist at NeuroNexus, Rosie works on the Radiens software development team to optimize features that best serve the scientific community. She also partners directly with users to help them fully leverage the Radiens platform, supporting projects from experimental design through publication submission. Rosie received her B.S. in Molecular Neuroscience from North Central College and her Ph.D. in Biomedical Sciences from the Medical University of South Carolina.
NEL Group, Inc. Board of Directors
Daryl R. Kipke
Director, NEL Group, Inc. and NeuroNexus
Founder and CEO of NeuroNexus. Formed the NEL Group in 2019 to buy the company back and lead it independently.
Thomas J. Hook
Director, NEL Group, Inc. and NeuroNexus
Thomas J. Hook is a Director of NEL Group, Inc. and NeuroNexus. He has led public and private companies in medical technology and precision manufacturing, as President and Chief Executive Officer of Barnes Group; Chief Executive Officer and Director of SaniSure, Inc.; Chief Executive Officer of Q Holding Company; and President, Chief Executive Officer and Chief Operating Officer of Integer (formerly Greatbatch). He earlier held leadership positions at CTI Molecular Imaging and General Electric Medical Systems, chaired the board of HealthNow New York, Inc., and served as a Director of Tactiva Therapeutics, Inc. He began his career as a nuclear engineer in the U.S. Navy, and holds an MBA from Vanderbilt University, a master's degree in chemistry from the State University of New York at Buffalo, and a B.S. in chemistry and mathematics from St. Bonaventure University.
Ownership
NeuroNexus Technologies, Inc. is the operating company of NEL Group, Inc., an Ann Arbor investment company focused on neuromodulation, neuroscience, cardiology and the life sciences. NEL Group wholly owns NeuroNexus and operates it to reinvest in its technology platforms and product development. Daryl Kipke and Thomas Hook are the directors of both companies; the three founders run NeuroNexus day to day.
Careers
NeuroNexus offers competitive pay and benefits and work on products that reach research labs worldwide. If your experience fits the work and you share the values above, write to us.
Contact
NeuroNexus is headquartered in Ann Arbor, Michigan.
Address
640 Avis Drive, Suite 200
Ann Arbor, MI 48108
United States
Email and phone
sales@neuronexus.com
support@neuronexus.com
+1 734 913 8858
Hours
Monday – Friday, 9:00 AM – 5:00 PM ET